These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7606009)

  • 1. Iodine-mediated inactivation of lipid- and nonlipid-enveloped viruses in human antithrombin III concentrate.
    Highsmith F; Xue H; Chen X; Benade L; Owens J; Shanbrom E; Drohan W
    Blood; 1995 Jul; 86(2):791-6. PubMed ID: 7606009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus reduction in the preparation of intravenous immune globulin: in vitro experiments.
    Chandra S; Cavanaugh JE; Lin CM; Pierre-Jerome C; Yerram N; Weeks R; Flanigan E; Feldman F
    Transfusion; 1999 Mar; 39(3):249-57. PubMed ID: 10204586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of lipid enveloped viruses by octanoic Acid treatment of immunoglobulin solution.
    Dichtelmüller H; Rudnick D; Kloft M
    Biologicals; 2002 Jun; 30(2):135-42. PubMed ID: 12127315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids.
    Horowitz B; Piët MP; Prince AM; Edwards CA; Lippin A; Walakovits LA
    Vox Sang; 1988; 54(1):14-20. PubMed ID: 2831669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected.
    Besselink GA; Van Engelenburg FA; Korsten HG; Blokker DE; Lagerberg JW; Brand A; De Korte D; Verhoeven AJ
    Transfusion; 2002 Jun; 42(6):728-33. PubMed ID: 12147025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of viruses in blood with aluminum phthalocyanine derivatives.
    Horowitz B; Williams B; Rywkin S; Prince AM; Pascual D; Geacintov N; Valinsky J
    Transfusion; 1991 Feb; 31(2):102-8. PubMed ID: 1847558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral validation of the bio-globulin production process].
    Zahorska R; Buchowicz I
    Med Dosw Mikrobiol; 1995; 47(1-2):89-94. PubMed ID: 8523973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses.
    Leavitt R; Schlesinger S; Kornfeld S
    J Virol; 1977 Jan; 21(1):375-85. PubMed ID: 189071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells.
    Czarniecki CW; Allen PT
    Antiviral Res; 1984 Dec; 4(6):351-5. PubMed ID: 6099710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of viruses by pasteurization at 60 °C for 10 h with and without 40% glucose as stabilizer during a new manufacturing process of α2-Macroglobulin from Cohn Fraction IV.
    Huangfu C; Ma Y; Jia J; Lv M; Zhu F; Ma X; Zhao X; Zhang J
    Biologicals; 2017 Mar; 46():139-142. PubMed ID: 28215695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus removal or inactivation in hemoglobin solutions by ultrafiltration or detergent/solvent treatment.
    Bechtel MK; Bagdasarian A; Olson WP; Estep TN
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):123-8. PubMed ID: 2846096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process.
    Bos OJ; Sunyé DG; Nieuweboer CE; van Engelenburg FA; Schuitemaker H; Over J
    Biologicals; 1998 Dec; 26(4):267-76. PubMed ID: 10403030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis.
    Vollenbroich D; Ozel M; Vater J; Kamp RM; Pauli G
    Biologicals; 1997 Sep; 25(3):289-97. PubMed ID: 9324997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of viruses (human immunodeficiency, hepatitis B, vesicular stomatitis and Sindbis viruses) from an intravenous immunoglobulin preparation.
    Hamamoto Y; Harada S; Yamamoto N; Uemura Y; Goto T; Suyama T
    Vox Sang; 1987; 53(2):65-9. PubMed ID: 2825431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization.
    Wagner SJ; Robinette D; Storry J; Chen XY; Shumaker J; Benade L
    Transfusion; 1994 Jun; 34(6):521-6. PubMed ID: 8023394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of viral inactivation during pH 3.3 pepsin digestion and caprylic acid treatment of antivenoms.
    Burnouf T; Terpstra F; Habib G; Seddik S
    Biologicals; 2007 Oct; 35(4):329-34. PubMed ID: 17363271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of lipid-enveloped and non-lipid-enveloped model viruses in normal human plasma by crosslinked starch-iodine.
    Highsmith FA; Xue H; Caple M; Walthall B; Drohan WN; Shanbrom E
    Transfusion; 1994 Apr; 34(4):322-7. PubMed ID: 8178330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the biological action of transition metal complexes. 3. About the antiviral activity of cis-dichloro diammine platinum (II) (author's transl)].
    Tonew E; Tonew M; Heyn B; Schröer HP
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):417-24. PubMed ID: 6277096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manufacturing process of anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance.
    Morrica A; Nardini C; Falbo A; Bailey AC; Bucci E
    Biologicals; 2003 Sep; 31(3):165-73. PubMed ID: 12935804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low pH, caprylate incubation as a second viral inactivation step in the manufacture of albumin. Parametric and validation studies.
    Johnston A; Uren E; Johnstone D; Wu J
    Biologicals; 2003 Sep; 31(3):213-21. PubMed ID: 12935811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.